SCHEMBL21167327

SCHEMBL21167327

N=C/C(=C\NCCO)c1cnc(N)c(NCc2c[nH]c3ncccc23)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.37
MTNR1A P48039 1/20 0.35
CDK2 P24941 6/20 0.35
GSK3B P49841 4/20 0.35
CDC7 O00311 3/20 0.35
MAP4K4 O95819 3/20 0.35
PIM1 P11309 3/20 0.35
PRKACA P17612 3/20 0.35
HIPK2 Q9H2X6 3/20 0.35
IRAK4 Q9NWZ3 3/20 0.35
ROCK2 O75116 2/20 0.35
MET P08581 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
TBK1 Q9UHD2 1/20 0.34
HDAC1 Q13547 1/20 0.33
CCNT1 O60563 2/20 0.33
CCNA2 P20248 2/20 0.33
CDK9 P50750 2/20 0.33
PDPK1 O15530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22475922 0.85 CDC7 (0.31) CDK2GSK3BCDC7MAP4K4PIM1
SCHEMBL22475654 0.79
SCHEMBL21167807 0.76 SYK (0.32) MET
SCHEMBL2197248 0.75 GPR84 (0.50) GPR84MTNR1ACDK2GSK3BCDC7
SCHEMBL22475879 0.75 CDC7 (0.32) CDK2GSK3BCDC7MAP4K4PIM1
SCHEMBL22475684 0.74
SCHEMBL22475937 0.74 LDHA (0.32) MET
SCHEMBL22475662 0.73 KEAP1 (0.36) METHDAC1
SCHEMBL22475947 0.72
SCHEMBL22475838 0.72 GPR84 (0.35) GPR84MTNR1ACDK2GSK3BCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed